Skip to main content
Erschienen in: Inflammation 1/2024

08.10.2023 | RESEARCH

Manganese Exacerbates ConA-Induced Liver Inflammation via the cGAS-STING Signaling Pathway

verfasst von: Kaidireya Saimaier, Sanxing Han, Jie Lv, Wei Zhuang, Ling Xie, Guangyu Liu, Chun Wang, Ru Zhang, Qiuhong Hua, Changjie Shi, Changsheng Du

Erschienen in: Inflammation | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

There is a potential association between the dysregulation of trace elements and impaired liver function. Elevated levels of manganese, an essential metal ion, have been observed in liver-related diseases, and excessive intake of manganese can worsen liver damage. However, the specific mechanisms underlying manganese-induced liver injury are not well understood. The aim of our study was to investigate the effects of excess manganese on autoimmune hepatitis (AIH) and elucidate its mechanisms. Our findings revealed that manganese exacerbates liver damage under ConA-induced inflammatory conditions. Transcriptomic and experimental data suggested that manganese enhances inflammatory signaling and contributes to the inflammatory microenvironment in the liver of AIH mice. Further investigations demonstrated that manganese exacerbates liver injury by activating the cGAS-STING signaling pathway and its downstream pro-inflammatory factors such as IFN\(\alpha\), IFN\(\beta\), TNF\(\alpha\), and IL-6 in the liver of AIH mice. These results suggest that manganese overload promotes the progression of AIH by activating cGAS-STING-mediated inflammation, providing a new perspective for the treatment and prognosis of AIH.
Literatur
1.
Zurück zum Zitat Horning, K.J., S.W. Caito, K.G. Tipps, A.B. Bowman, and M. Aschner. 2015. Manganese is essential for neuronal health. Annual Review of Nutrition 35: 71–108.PubMedPubMedCentralCrossRef Horning, K.J., S.W. Caito, K.G. Tipps, A.B. Bowman, and M. Aschner. 2015. Manganese is essential for neuronal health. Annual Review of Nutrition 35: 71–108.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Keen, C.L., J.L. Ensunsa, M.H. Watson, D.L. Baly, S.M. Donovan, M.H. Monaco, et al. 1999. Nutritional aspects of manganese from experimental studies. Neurotoxicology 20: 213–223.PubMed Keen, C.L., J.L. Ensunsa, M.H. Watson, D.L. Baly, S.M. Donovan, M.H. Monaco, et al. 1999. Nutritional aspects of manganese from experimental studies. Neurotoxicology 20: 213–223.PubMed
3.
Zurück zum Zitat Gandhi, D., A.P. Rudrashetti, and S. Rajasekaran. 2022. The impact of environmental and occupational exposures of manganese on pulmonary, hepatic, and renal functions. Journal of Applied Toxicology 42: 103–129.PubMedCrossRef Gandhi, D., A.P. Rudrashetti, and S. Rajasekaran. 2022. The impact of environmental and occupational exposures of manganese on pulmonary, hepatic, and renal functions. Journal of Applied Toxicology 42: 103–129.PubMedCrossRef
4.
5.
Zurück zum Zitat Nakayama, A., H. Fukuda, M. Ebara, H. Hamasaki, K. Nakajima, and H. Sakurai. 2002. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biological and Pharmaceutical Bulletin 25: 426–431.PubMedCrossRef Nakayama, A., H. Fukuda, M. Ebara, H. Hamasaki, K. Nakajima, and H. Sakurai. 2002. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biological and Pharmaceutical Bulletin 25: 426–431.PubMedCrossRef
6.
Zurück zum Zitat Versieck, J., F. Barbier, A. Speecke, and J. Hoste. 1974. Manganese, copper, and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis, and posthepatitic cirrhosis. Clinical Chemistry 20: 1141–1145.PubMedCrossRef Versieck, J., F. Barbier, A. Speecke, and J. Hoste. 1974. Manganese, copper, and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis, and posthepatitic cirrhosis. Clinical Chemistry 20: 1141–1145.PubMedCrossRef
7.
Zurück zum Zitat Liu, J., L. Tan, Z. Liu, and R. Shi. 2023. Blood and urine manganese exposure in non-alcoholic fatty liver disease and advanced liver fibrosis: An observational study. Environmental Science and Pollution Research International 30: 22222–22231.PubMedCrossRef Liu, J., L. Tan, Z. Liu, and R. Shi. 2023. Blood and urine manganese exposure in non-alcoholic fatty liver disease and advanced liver fibrosis: An observational study. Environmental Science and Pollution Research International 30: 22222–22231.PubMedCrossRef
8.
Zurück zum Zitat Leyva-Illades, D., P. Chen, C.E. Zogzas, S. Hutchens, J.M. Mercado, C.D. Swaim, et al. 2014. SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. Journal of Neuroscience 34: 14079–14095.PubMedCrossRef Leyva-Illades, D., P. Chen, C.E. Zogzas, S. Hutchens, J.M. Mercado, C.D. Swaim, et al. 2014. SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. Journal of Neuroscience 34: 14079–14095.PubMedCrossRef
9.
Zurück zum Zitat Quadri, M., A. Federico, T. Zhao, G.J. Breedveld, C. Battisti, C. Delnooz, et al. 2012. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. American Journal of Human Genetics 90: 467–477.PubMedPubMedCentralCrossRef Quadri, M., A. Federico, T. Zhao, G.J. Breedveld, C. Battisti, C. Delnooz, et al. 2012. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. American Journal of Human Genetics 90: 467–477.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Ward, L.D., H.C. Tu, C.B. Quenneville, S. Tsour, A.O. Flynn-Carroll, M.M. Parker, et al. 2021. GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms. Nature Communications 12: 4571.PubMedPubMedCentralCrossRef Ward, L.D., H.C. Tu, C.B. Quenneville, S. Tsour, A.O. Flynn-Carroll, M.M. Parker, et al. 2021. GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms. Nature Communications 12: 4571.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Rashed, M.N. 2011. The role of trace elements on hepatitis virus infections: A review. Journal of Trace Elements in Medicine and Biology 25: 181–187.PubMedCrossRef Rashed, M.N. 2011. The role of trace elements on hepatitis virus infections: A review. Journal of Trace Elements in Medicine and Biology 25: 181–187.PubMedCrossRef
12.
Zurück zum Zitat Webb, G.J., G.M. Hirschfield, E.L. Krawitt, and M.E. Gershwin. 2018. Cellular and molecular mechanisms of autoimmune hepatitis. Annual Review of Pathology: Mechanisms of Disease 13: 247–292.CrossRef Webb, G.J., G.M. Hirschfield, E.L. Krawitt, and M.E. Gershwin. 2018. Cellular and molecular mechanisms of autoimmune hepatitis. Annual Review of Pathology: Mechanisms of Disease 13: 247–292.CrossRef
13.
Zurück zum Zitat Fan, J.H., G.F. Liu, X.D. Lv, R.Z. Zeng, L.L. Zhan, and X.P. Lv. 2021. Pathogenesis of autoimmune hepatitis. World Journal of Hepatology 13: 879–886.PubMedPubMedCentralCrossRef Fan, J.H., G.F. Liu, X.D. Lv, R.Z. Zeng, L.L. Zhan, and X.P. Lv. 2021. Pathogenesis of autoimmune hepatitis. World Journal of Hepatology 13: 879–886.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Floreani, A., P. Restrepo-Jiménez, M.F. Secchi, S. De Martin, P.S.C. Leung, E. Krawitt, et al. 2018. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 95: 133–143.PubMedCrossRef Floreani, A., P. Restrepo-Jiménez, M.F. Secchi, S. De Martin, P.S.C. Leung, E. Krawitt, et al. 2018. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 95: 133–143.PubMedCrossRef
15.
Zurück zum Zitat Jones, D.B., and C.O. Johns. 1916. Some proteins from the jack bean, Canavalia Ensiformis. Journal of Biological Chemistry 28: 67–75.CrossRef Jones, D.B., and C.O. Johns. 1916. Some proteins from the jack bean, Canavalia Ensiformis. Journal of Biological Chemistry 28: 67–75.CrossRef
16.
Zurück zum Zitat Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. The Journal of Clinical Investigation 90: 196–203.PubMedPubMedCentralCrossRef Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. The Journal of Clinical Investigation 90: 196–203.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Liu, Y., H. Hao, and T. Hou. 2022. Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook. Open Life Sciences 17: 91–101.PubMedPubMedCentralCrossRef Liu, Y., H. Hao, and T. Hou. 2022. Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook. Open Life Sciences 17: 91–101.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Kusters, S., F. Gantner, G. Kunstle, and G. Tiegs. 1996. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111: 462–471.PubMedCrossRef Kusters, S., F. Gantner, G. Kunstle, and G. Tiegs. 1996. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111: 462–471.PubMedCrossRef
19.
Zurück zum Zitat Srisuchart, B., M.J. Taylor, and R.P. Sharma. 1987. Alteration of humoral and cellular immunity in manganese chloride-treated mice. Journal of Toxicology and Environment Health 22: 91–99.CrossRef Srisuchart, B., M.J. Taylor, and R.P. Sharma. 1987. Alteration of humoral and cellular immunity in manganese chloride-treated mice. Journal of Toxicology and Environment Health 22: 91–99.CrossRef
20.
Zurück zum Zitat Wang, C., Y. Guan, M. Lv, R. Zhang, Z. Guo, X. Wei, et al. 2018. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and Is required for the host defense against DNA viruses. Immunity 48: 675-687.e7.PubMedCrossRef Wang, C., Y. Guan, M. Lv, R. Zhang, Z. Guo, X. Wei, et al. 2018. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and Is required for the host defense against DNA viruses. Immunity 48: 675-687.e7.PubMedCrossRef
21.
Zurück zum Zitat Zhang, R., W. Yang, H. Zhu, J. Zhai, M. Xue, and C. Zheng. 2023. NLRC4 promotes the cGAS-STING signaling pathway by facilitating CBL-mediated K63-linked polyubiquitination of TBK1. Journal of Medical Virology 95: e29013.PubMedCrossRef Zhang, R., W. Yang, H. Zhu, J. Zhai, M. Xue, and C. Zheng. 2023. NLRC4 promotes the cGAS-STING signaling pathway by facilitating CBL-mediated K63-linked polyubiquitination of TBK1. Journal of Medical Virology 95: e29013.PubMedCrossRef
22.
Zurück zum Zitat Xu, H., C. Su, A. Pearson, C.H. Mody, and C. Zheng. 2017. Herpes Simplex Virus 1 UL24 abrogates the DNA sensing signal pathway by inhibiting NF-κB activation. Journal of Virology 91: e00025-17. Xu, H., C. Su, A. Pearson, C.H. Mody, and C. Zheng. 2017. Herpes Simplex Virus 1 UL24 abrogates the DNA sensing signal pathway by inhibiting NF-κB activation. Journal of Virology 91: e00025-17.
23.
Zurück zum Zitat Chen, K., C. Lai, Y. Su, W.D. Bao, L.N. Yang, P.P. Xu, et al. 2022. cGAS-STING-mediated IFN-I response in host defense and neuroinflammatory diseases. Current Neuropharmacology 20: 362–371.PubMedPubMedCentralCrossRef Chen, K., C. Lai, Y. Su, W.D. Bao, L.N. Yang, P.P. Xu, et al. 2022. cGAS-STING-mediated IFN-I response in host defense and neuroinflammatory diseases. Current Neuropharmacology 20: 362–371.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat García-Buey, L., C. García-Monzón, S. Rodriguez, M.J. Borque, A. García-Sánchez, R. Iglesias, et al. 1995. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108: 1770–1777.PubMedCrossRef García-Buey, L., C. García-Monzón, S. Rodriguez, M.J. Borque, A. García-Sánchez, R. Iglesias, et al. 1995. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108: 1770–1777.PubMedCrossRef
25.
Zurück zum Zitat Villamil, A., E. Mullen, P. Casciato, and A. Gadano. 2015. Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: Report of two cases and review of the literature. Annals of Hepatology 14: 273–280.PubMedCrossRef Villamil, A., E. Mullen, P. Casciato, and A. Gadano. 2015. Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: Report of two cases and review of the literature. Annals of Hepatology 14: 273–280.PubMedCrossRef
26.
Zurück zum Zitat Hao, J., W. Sun, and H. Xu. 2022. Pathogenesis of concanavalin A induced autoimmune hepatitis in mice. International Immunopharmacology 102: 108411.PubMedCrossRef Hao, J., W. Sun, and H. Xu. 2022. Pathogenesis of concanavalin A induced autoimmune hepatitis in mice. International Immunopharmacology 102: 108411.PubMedCrossRef
27.
Zurück zum Zitat Decout, A., J.D. Katz, S. Venkatraman, and A. Ablasser. 2021. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nature Reviews Immunology 21: 548–569.PubMedPubMedCentralCrossRef Decout, A., J.D. Katz, S. Venkatraman, and A. Ablasser. 2021. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nature Reviews Immunology 21: 548–569.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Grivennikov, S.I., A.V. Tumanov, D.J. Liepinsh, A.A. Kruglov, B.I. Marakusha, A.N. Shakhov, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: Protective and deleterious effects. Immunity 22: 93–104.PubMed Grivennikov, S.I., A.V. Tumanov, D.J. Liepinsh, A.A. Kruglov, B.I. Marakusha, A.N. Shakhov, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: Protective and deleterious effects. Immunity 22: 93–104.PubMed
29.
Zurück zum Zitat Mizuhara, H., E. O’Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, et al. 1994. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. Journal of Experimental Medicine 179: 1529–1537.PubMedCrossRef Mizuhara, H., E. O’Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, et al. 1994. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. Journal of Experimental Medicine 179: 1529–1537.PubMedCrossRef
30.
Zurück zum Zitat Brenner, C., L. Galluzzi, O. Kepp, and G. Kroemer. 2013. Decoding cell death signals in liver inflammation. Journal of Hepatology 59: 583–594.PubMedCrossRef Brenner, C., L. Galluzzi, O. Kepp, and G. Kroemer. 2013. Decoding cell death signals in liver inflammation. Journal of Hepatology 59: 583–594.PubMedCrossRef
31.
Zurück zum Zitat Knight, B., R. Lim, G.C. Yeoh, and J.K. Olynyk. 2007. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. Journal of Hepatology 47: 826–833.PubMedCrossRef Knight, B., R. Lim, G.C. Yeoh, and J.K. Olynyk. 2007. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. Journal of Hepatology 47: 826–833.PubMedCrossRef
32.
Zurück zum Zitat Toyonaga, T., O. Hino, S. Sugai, S. Wakasugi, K. Abe, M. Shichiri, et al. 1994. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proceedings of the National Academy of Sciences of the United States of America 91: 614–618.PubMedPubMedCentralCrossRef Toyonaga, T., O. Hino, S. Sugai, S. Wakasugi, K. Abe, M. Shichiri, et al. 1994. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proceedings of the National Academy of Sciences of the United States of America 91: 614–618.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Miyagi, T., T. Takehara, T. Tatsumi, T. Suzuki, M. Jinushi, Y. Kanazawa, et al. 2004. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver. Hepatology 40: 1190–1196.PubMedCrossRef Miyagi, T., T. Takehara, T. Tatsumi, T. Suzuki, M. Jinushi, Y. Kanazawa, et al. 2004. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver. Hepatology 40: 1190–1196.PubMedCrossRef
35.
Zurück zum Zitat Su, C., Y.D. Tang, and C. Zheng. 2021. DExD/H-box helicases: Multifunctional regulators in antiviral innate immunity. Cellular and Molecular Life Sciences 79: 2.PubMedPubMedCentralCrossRef Su, C., Y.D. Tang, and C. Zheng. 2021. DExD/H-box helicases: Multifunctional regulators in antiviral innate immunity. Cellular and Molecular Life Sciences 79: 2.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Berardi, S., F. Lodato, A. Gramenzi, A. D’Errico, M. Lenzi, A. Bontadini, et al. 2007. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: Possible de novo autoimmune hepatitis? Gut 56: 237–242.PubMedCrossRef Berardi, S., F. Lodato, A. Gramenzi, A. D’Errico, M. Lenzi, A. Bontadini, et al. 2007. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: Possible de novo autoimmune hepatitis? Gut 56: 237–242.PubMedCrossRef
37.
Zurück zum Zitat Hong, Z., J. Mei, H. Guo, J. Zhu, and C. Wang. 2022. Intervention of cGAS‒STING signaling in sterile inflammatory diseases. Journal of Molecular Cell Biology 14: mjac005. Hong, Z., J. Mei, H. Guo, J. Zhu, and C. Wang. 2022. Intervention of cGAS‒STING signaling in sterile inflammatory diseases. Journal of Molecular Cell Biology 14: mjac005.
38.
Zurück zum Zitat Zhang, R., C. Wang, Y. Guan, X. Wei, M. Sha, M. Yi, et al. 2021. Manganese salts function as potent adjuvants. Cellular & Molecular Immunology 18: 1222–1234.CrossRef Zhang, R., C. Wang, Y. Guan, X. Wei, M. Sha, M. Yi, et al. 2021. Manganese salts function as potent adjuvants. Cellular & Molecular Immunology 18: 1222–1234.CrossRef
39.
40.
Zurück zum Zitat Skopelja-Gardner, S., J. An, and K.B. Elkon. 2022. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nature Reviews Nephrology 18: 558–572.PubMedPubMedCentralCrossRef Skopelja-Gardner, S., J. An, and K.B. Elkon. 2022. Role of the cGAS-STING pathway in systemic and organ-specific diseases. Nature Reviews Nephrology 18: 558–572.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Motwani, M., S. Pesiridis, and K.A. Fitzgerald. 2019. DNA sensing by the cGAS-STING pathway in health and disease. Nature Reviews Genetics 20: 657–674.PubMedCrossRef Motwani, M., S. Pesiridis, and K.A. Fitzgerald. 2019. DNA sensing by the cGAS-STING pathway in health and disease. Nature Reviews Genetics 20: 657–674.PubMedCrossRef
42.
Zurück zum Zitat Wang, S., K. Wang, R. Lin, and C. Zheng. 2013. Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. Journal of Virology 87: 12814–12827.PubMedPubMedCentralCrossRef Wang, S., K. Wang, R. Lin, and C. Zheng. 2013. Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. Journal of Virology 87: 12814–12827.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Papo, T., P. Marcellin, J. Bernuau, F. Durand, T. Poynard, and J.P. Benhamou. 1992. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Annals of Internal Medicine 116: 51–53.PubMedCrossRef Papo, T., P. Marcellin, J. Bernuau, F. Durand, T. Poynard, and J.P. Benhamou. 1992. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Annals of Internal Medicine 116: 51–53.PubMedCrossRef
44.
Zurück zum Zitat Tana, M.M., A. Klepper, A. Lyden, A.O. Pisco, M. Phelps, B. McGee, et al. 2022. Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. PLoS ONE 17: e0264307.PubMedPubMedCentralCrossRef Tana, M.M., A. Klepper, A. Lyden, A.O. Pisco, M. Phelps, B. McGee, et al. 2022. Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. PLoS ONE 17: e0264307.PubMedPubMedCentralCrossRef
Metadaten
Titel
Manganese Exacerbates ConA-Induced Liver Inflammation via the cGAS-STING Signaling Pathway
verfasst von
Kaidireya Saimaier
Sanxing Han
Jie Lv
Wei Zhuang
Ling Xie
Guangyu Liu
Chun Wang
Ru Zhang
Qiuhong Hua
Changjie Shi
Changsheng Du
Publikationsdatum
08.10.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2024
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01912-4

Weitere Artikel der Ausgabe 1/2024

Inflammation 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

CKD bei Diabetes: Neuheiten und Zukunftsaussichten

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Jeder Mensch mit Diabetes muss auf eine chronische Nierenerkrankung gescreent werden – diese neue Empfehlung spricht die KDIGO aus. Die Therapie erfolgt individuell und je nach Szenario mit verschiedenen Substanzklassen. Künftig kommt wahrscheinlich, neben RAS-Hemmung, SGLT2-Inhibition und nsMRA, eine vierte Therapiesäule hinzu.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten im Schlagabtausch

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Wer hat die Nase vorn – SGLT2-Inhibitoren oder GLP-1-Rezeptoragonisten? Diese Frage diskutierten zwei Experten in einer Session auf dem diesjährigen Diabetes-Kongress.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.